New malaria drug candidate shows early promise in human study
From: QIMR Berghofer MMV367/GSK3772701 shows promise as a future treatment for malaria patients in the context of emerging drug resistance. It belongs to a novel class of molecules called pyrrolidinamides, that target the malaria parasite in a …